相关实验视频
Updated: Aug 14, 2026

14:54
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
Published on: January 27, 2019
11.0K
P2X7受体可能是新生儿败血症的潜在目标吗?
Sales Fialho1, Patrick Trieu-Cuot2, Paula Ferreira3
1Department of ImmunoPhysiology and Pharmacology, ICBAS - School of Medicine and Biomedical Sciences - University of Porto, Porto, Portugal.
International immunopharmacology
|September 6, 2024
概括
新生儿败血症每年导致数百万人的死亡. 针对P2X7受体 (P2X7R) 提供了一个有前途的新治疗策略,以对抗这一关键的全球健康问题.
科学领域:
- 免疫学 免疫学 免疫学
- 新生儿医学 新生儿医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 新生儿败血症是1个月以下婴儿死亡的主要原因.
- 抗生素耐药性和副作用需要新生儿败血症的新疗法.
- 世界卫生组织强调迫切需要新的败血症治疗和预防目标.
研究的目的:
- 审查新生儿败血症的免疫病理学.
- 探索P2X7受体 (P2X7R) 作为新生儿败血症治疗点的潜力.
- 在败血症的背景下分析P2X7R的免疫调节作用.
主要方法:
- 文献综述专注于新生儿败血症.
- 分析P2X7受体在炎症和免疫反应中的作用.
- 对免疫介导疾病中纯能系统点的现有研究进行了审查.
主要成果:
- P2X7受体是与败血症相关的炎症级联中的关键调解者.
- 纯能系统,特别是P2X7R,表现出重要的免疫调节功能.
- 有证据表明P2X7R在败血症中具有治疗干预的潜力.
结论:
- P2X7受体调节为新生儿败血症提供了一个可行的药理学策略.
- 准P2X7R可以减少新生儿败血症的全球负担.
- 对P2X7R通路的进一步研究是开发新治疗方法的必要条件.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...

